Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
8,9 USD | +3,25 % | +14,10 % | +505,44 % |
Resumen de negocios
Número de empleados: 42
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 01/09/20 |
Founder | 66 | 01/01/02 | |
Charles Schoch
DFI | Director of Finance/CFO | 39 | - |
Seshu Tyagarajan
CTO | Chief Tech/Sci/R&D Officer | 57 | 02/03/22 |
Francesca Barone
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/11/20 |
William Nichols
CTO | Chief Tech/Sci/R&D Officer | 55 | 12/09/22 |
Ileen B. Winick
HRO | Human Resources Officer | - | 01/01/21 |
Nathan Caffo
PRN | Corporate Officer/Principal | 55 | 01/09/20 |
Susan Stewart
LAW | General Counsel | 64 | 01/10/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Papa
BRD | Director/Board Member | 68 | 08/08/22 |
Edward Benz
BRD | Director/Board Member | 78 | 01/09/17 |
Paul Manning
CHM | Chairman | 68 | 01/11/18 |
Gary Nabel
BRD | Director/Board Member | 70 | 08/08/22 |
Founder | 66 | 01/01/02 | |
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 01/09/20 |
Renee Gaeta
BRD | Director/Board Member | 42 | 08/08/22 |
Diem Nguyen
BRD | Director/Board Member | 52 | 15/07/21 |
Director/Board Member | 45 | 01/11/18 | |
Nicoletta Loggia
BRD | Director/Board Member | - | 07/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 29 878 613 | 20 005 186 ( 66,95 %) | 122 608 ( 0,4104 %) | 66,95 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+505,44 % | 265 M | |
+43,36 % | 54,63 mil M | |
-5,31 % | 39,92 mil M | |
+14,75 % | 26,86 mil M | |
-12,56 % | 26,22 mil M | |
-22,45 % | 18,78 mil M | |
+25,12 % | 12,21 mil M | |
+0,04 % | 12,16 mil M | |
+26,04 % | 11,94 mil M | |
-11,83 % | 10,74 mil M |
- Bolsa de valores
- Acciones
- Acción CADL
- Empresa Candel Therapeutics, Inc.